Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Hvidberg

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1974
Problems in the organization of clinical pharmacology in DenmarkE F Hvidberg
Canadian Journal of Comparative Medicine : Revue Canadienne De Medecine Comparee|January 1, 1975
Pharmacokinetics of phenylbutazone and oxyphenabutazone in the pigE F Hvidberg, F Rasmussen
Clinical Pharmacokinetics|January 1, 1976
Clinical pharmacokinetics of anticonvulsantsE F Hvidberg, M Dam
Danish Medical Bulletin|February 1, 1990
Therapeutic trials in general practice, an unmet needE F Hvidberg, P A Pedersen
Clinical and Experimental Pharmacology & Physiology|September 1, 1976
Saturable metabolic pathways for ethotoin in manJ Naestoft, E F Hvidberg, O Sjö
Rational Drug Therapy|July 1, 1986
Rational choice of dose: insufficient background knowledge?P C Gøtzsche, E F Hvidberg, P Juul
European Journal of Clinical Pharmacology|November 9, 1978
Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patientsM L Friis, J Christiansen, E F Hvidberg
Clinical Chemistry|June 1, 1976
Rapid radioimmunoassay for methotrexate in biological fluidsJ Hendel, L J Sarek, E F Hvidberg
The Journal of Antimicrobial Chemotherapy|October 1, 1987
Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patientsS S Pedersen, T Jensen, E F Hvidberg
Clinical Pharmacology and Therapeutics|February 1, 1974
Plasma half-life of phenylbutazone in patients with impaired liver functionE F Hvidberg, P B Andreasen, L Ranek
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|September 1, 1974
Problems in the organization of clinical pharmacology in DenmarkE F Hvidberg
Canadian Journal of Comparative Medicine : Revue Canadienne De Medecine Comparee|January 1, 1975
Pharmacokinetics of phenylbutazone and oxyphenabutazone in the pigE F Hvidberg, F Rasmussen
Clinical Pharmacokinetics|January 1, 1976
Clinical pharmacokinetics of anticonvulsantsE F Hvidberg, M Dam
Danish Medical Bulletin|February 1, 1990
Therapeutic trials in general practice, an unmet needE F Hvidberg, P A Pedersen
Clinical and Experimental Pharmacology & Physiology|September 1, 1976
Saturable metabolic pathways for ethotoin in manJ Naestoft, E F Hvidberg, O Sjö
Rational Drug Therapy|July 1, 1986
Rational choice of dose: insufficient background knowledge?P C Gøtzsche, E F Hvidberg, P Juul
European Journal of Clinical Pharmacology|November 9, 1978
Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patientsM L Friis, J Christiansen, E F Hvidberg
Clinical Chemistry|June 1, 1976
Rapid radioimmunoassay for methotrexate in biological fluidsJ Hendel, L J Sarek, E F Hvidberg
The Journal of Antimicrobial Chemotherapy|October 1, 1987
Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patientsS S Pedersen, T Jensen, E F Hvidberg
Clinical Pharmacology and Therapeutics|February 1, 1974
Plasma half-life of phenylbutazone in patients with impaired liver functionE F Hvidberg, P B Andreasen, L Ranek
Pageof 8